Keith Flaherty

Keith FlahertyKeith Flaherty
KF

Keith Flaherty

Director of Clinical Research at Massachusetts General Hospital Cancer Center, Professor at Harvard Medical School

About

Keith Flaherty is a physician, scientist, and founder with expertise in therapeutic cancer biomarkers. He is the Director of Clinical Research at the Massachusetts General Hospital Cancer Center and a Professor of Medicine at Harvard Medical School. He has founded multiple therapeutic and diagnostic ventures, including X4 Pharmaceuticals, Strata Oncology, Scorpion Therapeutics, Apricity Health, and Loxo Oncology.
Frequently asked

Who is Keith Flaherty?

Keith Flaherty is a physician, scientist, and founder with expertise in therapeutic cancer biomarkers. He is the Director of Clinical Research at the Massachusetts General Hospital Cancer Center and a Professor of Medicine at Harvard Medical School. He has founded multiple therapeutic and diagnostic ventures, including X4 Pharmaceuticals, Strata Oncology, Scorpion Therapeutics, Apricity Health, an…

What is Keith Flaherty's current role?

Keith Flaherty is currently Director of Clinical Research at Massachusetts General Hospital Cancer Center, Professor at Harvard Medical School.

Comments

No comments yet. Be the first to share your take.

Profile

About Keith Flaherty

Keith Flaherty is Director of Clinical Research at Massachusetts General Hospital Cancer Center, Professor at Harvard Medical School. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.